ResMed is seeing "almost unlimited demand" for its sleep apnea machines, thanks to a massive and ongoing recall by its largest competitor, Philips. The problem is that the San Diego, CA-based company ...
2030 ambition to help more than 500 million people worldwide achieve their full health potential Showcases integration of intelligent products and solutions within the ResMed ecosystem, designed to ...
SYDNEY, Feb 3 (Reuters) - Sleep-breathing device maker ResMed plans to take global a doctor education program aimed at promoting the screening of patients seeking Ozempic-style weight loss drugs for ...
ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
ResMed makes it easier for people to manage their sleep health and stay on (continuous positive airway pressure) CPAP treatment by integrating its leading myAir™ consumer app with Apple and Android ...
ResMed's shares have fallen 37% due to struggles with profitability and investor fears of weight loss drugs, but I believe in its long-term potential. The company reported a 16% increase in revenue ...
Barchart on MSN
Is ResMed stock underperforming the Nasdaq?
ResMed Inc. (RMD), headquartered in San Diego, California, manufactures, distributes, and markets medical devices and cloud-based software applications. Valued at $36 billion by market cap, the ...
ResMed (NYSE:RMD) is opening a new major distribution center in Greenwood, Indiana, to support its North American logistics network. The facility is planned to create over 100 jobs and will work ...
Some investors in ResMed, which makes machines for people with sleep apnea, think that effective new weight-loss drugs could shrink its addressable market. On ResMed's latest earnings call, CEO Mick ...
Earnings call ResMed reported Q1 FY26 revenue of $1.34B, up 9% YoY (8% in constant currency), driven by 8% device and 10% mask growth globally. Gross margin expanded 280bps YoY to 62%, and EPS rose 16 ...
ResMed Inc. (NYSE:RMD) is one of the best medical technology stocks to invest in. On January 30, KeyBanc Capital Markets lifted its price target on ResMed Inc. (NYSE:RMD) to $302 from $299 and ...
WANE 15 on MSN
Braun: Resmed to build $30 million facility in Greenwood
GREENWOOD, Ind. — Officials with the Indiana Office of Commerce and the office of Indiana Gov. Mike Braun announced on Tuesday that a new company centered on health technology will establish its first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results